COMMUNITY PROFILE



Roger Martin, Founder & President of Roger l. Martin, Inc. and Professor Emeritus, Rotman School of Management,

Roger Martin

Founder & President of Roger l. Martin, Inc. and Professor Emeritus, Rotman School of Management

In 2017, Roger was named the world’s #1 management thinker by Thinkers50, a biannual ranking of the most influential global business thinkers.

Roger is a trusted strategy advisor to the CEOs of companies worldwide including Procter & Gamble, Lego and Ford.

Roger Martin is a Professor Emeritus at the Rotman School of Management at University of Toronto where he served as Dean from 1998-2013, Academic Director of the Michael Lee-Chin Family Institute for Corporate Citizenship from 2004-2019 and Institute Director of the Martin Prosperity Institute from 2013-2019. In 2013, he was named global Dean of the Year by the leading business school website, Poets & Quants.

His newest book is When More is Not Better: Overcoming America’s Obsession with Economic Efficiency (Harvard Business Review Press, 2020). His previous eleven books include Creating Great Choices written with Jennifer Riel (HBRP, 2017) Getting Beyond Better written with Sally Osberg (HBRP, 2015) and Playing to Win written with A.G. Lafley (HBRP, 2013), which won the award for Best Book of 2012-13 by the Thinkers50. He has written 29 Harvard Business Review articles.

Roger received his BA from Harvard College, with a concentration in Economics, in 1979 and his MBA from the Harvard Business School in 1981. He lives in South Florida with his wife, Marie-Louise Skafte.


Areas of Interest

- Strategy
- Integrative Thinking
- Business Design
- Corporate Social Responsibility
- Country Competitiveness

 


Redwood Bank NATS Salesforce E.ON UK LDC Bunzl plc Veolia Water Technologies Concentrix + Webhelp Legal & General Investment Management Tullow Oil plc Royal London Group Google Eton Bridge Partners Mayborn Group Eightfold AI Robert Walters London Stock Exchange Amazon UK Drax Group plc AlixPartners Accenture Workday GlaxoSmithKline plc Lightsource bp